Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2

Oncogene

Volumn 28, Issue 23, 2009, Pages 2299-2304

  Gammoh, N ^a   Isaacson, E ^b   Tomaic V ^a   Jackson, D J ^b   Doorbar, J ^b   Banks, L ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Centrosomes; E7; HPV; PRb

Indexed keywords

PROTEIN E2; PROTEIN E6; PROTEIN E7; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CENTROSOME; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; MITOSIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CENTROSOME; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; ONCOGENE PROTEINS, VIRAL; PLASMIDS; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 67349228752     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.78     Document Type: Article

References (18)

1. Araujo FD, Stracker TH, Carson CT, Lee DV, Weitzman MD. (2005). Adenovirus type 5 E4orf3 protein targets the Mre 11 complex to cytoplasmic aggresomes. J Virol 79: 11382-11391.
2. Boyer SN, Wazer DE, Band V. (1996). E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56: 4620-4624.
3. Donaldson MM, Boner W, Morgan IM. (2007). TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J Virol 81: 4338-4342.
4. Doorbar J. (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (London) 110: 525-541.
5. Duensing S, Duensing A, Flores ER, Do A, Lambert PF, Münger K. (2001). Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J Virol 75: 7712-7716.
6. Duensing S, Duensing A, Lee DC, Edwards KM, Piboonniyom SO, Manuel E et al. (2004). Cyclin-dependent kinase inhibitor indirubin-3́-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene 23: 8206-8215.
7. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S et al. (2000). The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002-10007.
8. Duensing S, Münger K. (2003). Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 11: 12331-12335.
9. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. (1997). Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11: 2090-2100.
10. Gammoh N, Grm HS, Massimi P, Banks L. (2006). Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator. J Virol 80: 1787-1797.
11. Grm HS, Massimi P, Gammoh N, Banks L. (2005). Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24: 5149-5164.
12. He W, Staples D, Smith C, Fisher C. (2003). Direct activation of cyclin- dependent kinase 2 by human papillomavirus E7. J Virol 11: 10566-10574.
13. Heck DV, Yee CL, Howley PM, Münger K. (1992). Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 89: 4442-4446.
14. Kurg R, Sild K, Ilves A, Sepp M, Ustav M. (2005). Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J Virol 79: 10528- 10539.
15. Massimi P, Pim D, Bertoli C, Bouvard V, Banks L. (1999). Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18: 7748-7754.
16. 2-M-phase proteins. Cancer Res 64: 1299-1306.
17. Vogelstein B, Kinzler KW. (2004). Cancer genes and the pathways they control. Nat Med 10: 789-799.
18. Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y et al. (2003). in vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 8: 762-768.